The Kenyan diaspora in Norway combines a strong healthcare workforce presence, educational pathways and a growing professional community across Oslo, Bergen, Trondheim and Stavanger. Explore the community profile, employment sectors and the Kenya-Norway relationship.
One in four Kenyans experiences a mental health condition in their lifetime, yet mental health receives a small fraction of health spending. Explore Mathari Hospital, the Mental Health Act 2022, the workforce shortage, NACADA and the path to community-based care.
Prostate cancer is the most common cancer in Kenyan men, with roughly 3,500-4,200 new cases yearly and most presenting late. Explore PSA screening, the diagnostic pathway, treatment options at Kenyatta, Moi, Aga Khan and county hospitals, and the NHIF cancer package.
Kenya records about 5,250 new cervical cancer cases and 3,200 deaths a year. This article maps the HPV vaccination rollout, VIA screening, treatment access, the HIV link and the path toward WHO's 90-70-90 elimination targets.
A deep look at hypertension in Kenya — covering disease burden, diagnosis at primary care level, treatment pathways under the Social Health Authority and the long road to population-wide blood pressure control across all 47 counties.
Sickle cell disease affects roughly 14,000 Kenyan newborns each year, concentrated in the lake and coastal counties. This article maps prevalence, newborn screening, hydroxyurea access, comprehensive care centres and the social and financing barriers families face across Kenya.
The University of Nairobi traces its lineage to the Royal Technical College of 1956 and today runs six colleges, eleven faculties and more than three hundred programmes that have trained the majority of Kenya's senior public servants, doctors, engineers and academics.
Type 2 diabetes is one of Kenya's fastest-growing chronic conditions, with national survey data showing a 3.1 percent adult prevalence, low awareness and a structural treatment gap that the National NCD Strategic Plan 2021-2026 is trying to close at primary-care level.
Tuberculosis remains one of the leading causes of death from a single infectious agent in Kenya, but two decades of investment in the National Leprosy, Tuberculosis and Lung Disease Programme have substantially reduced incidence, mortality and undiagnosed cases.
Cookies on this site
We use cookies to keep this site running and, with your consent, to understand how visitors use it. You can change your choice anytime in our Cookie Notice.